Arsenic and human health
The International Agency for Research on Cancer has classifi ed arsenic as a class I human carcinogen (7) . Arsenic in drinking water has been associated with increased risk of a wide range of health outcomes including cancers of the skin, lung, bladder, liver, and kidney (8 -12) , neurological disease (13) , cardiovascular disease (14) , as well as other non-malignant diseases (15, 16) .
Although arsenic is a well-established human carcinogen (17) and has additionally been associated with an array of chronic diseases through epidemiologic investigations (8 -13, 18 -25) , the underlying mechanism(s) of some aspects of arsenic toxicity has not yet been determined. This is largely due to the absence of a suitable animal model for the evaluation of arsenic toxicity (26, 27) . Additionally, although the health effects of arsenic exposure through drinking water have been well-established at higher doses ( > 100 μ g/L), evidence on the effects of arsenic at low to moderate levels ( < 100 μ g/L) of exposure is not well-established. Arsenic exposure at low to moderate levels is more prevalent than high-level exposure, and even a small increased risk may translate to a large number of excess cases and be of public health concern. Epidemiologic investigations of health effects at these lower arsenic concentrations are of potentially substantial public
Introduction
Arsenic is a naturally occurring metalloid that is ubiquitously present in the environment. Through reduction-oxidation reactions, arsenic can be released from soil and rock into the surrounding aquifers. Elevated concentrations of arsenic in groundwater were fi rst realized in West Bengal, India, and Bangladesh in the 1980s and 1990s with the appearance of skin lesion epidemics in villages, which accessed drinking water by tube wells that tap into the arsenic-enriched aquifers (1) . The tube wells were installed through government and public health initiatives beginning in the 1970s to provide microbially safe drinking water to the population through the consumption of groundwater. This was an effort to reduce mortality and morbidity from cholera and other waterborne diseases that had plagued the population and proved to be effective toward this end with the subsequent reduction of health relevance for both developed and developing nations worldwide in providing a better basis for planning population interventions and policy decisions.
Although the mechanisms of arsenic toxicity have yet to be established, recent advances have been made in arsenic epidemiology with the use of genetic and molecular techniques to shed light on the underlying mechanisms of arsenic toxicity.
Recent fi ndings from genetic and molecular epidemiology Arsenic metabolism
Arsenic is primarily present in the inorganic form (arsenate and arsenite) in drinking water (28) . Once internalized, it goes through a series of reduction and oxidative methylation steps (29) . Although the methylation of an exogenous compound is typically considered to be a detoxifi cation process, there is mounting evidence that the partial methylation of arsenic may increase its toxicity in vivo particularly via the trivalent monomethylated arsenic (MMA) species that is more toxic than the inorganic and pentavalent methylated arsenic species (30 -33) . Ingested inorganic arsenic is typically excreted as 10 % -20 % inorganic arsenic, 10 % -15 % MMA, and 60 % -75 % dimethylated arsenic (DMA) (34) . However, there is known interindividual variability in the methylation capacity of arsenic [as reviewed by Tseng (35) ], which has been hypothesized to partly explain the variability in susceptibility to arsenic toxicity.
Recently, the fi rst genomewide association study (GWAS) of arsenic-related metabolism and toxicity phenotypes was conducted (36) , which utilized data on urinary arsenic metabolite concentrations and 259,597 genomewide single nucleotide polymorphisms (SNPs) for 1313 arsenic-exposed Bangladeshi individuals. Five SNPs (rs4919694, rs9527, rs4290163, rs11191527, and rs11191659) near the AS3MT gene (arsenite methyltransferase; 10q24.32) showed significant independent associations for urinary total MMA percentage and total DMA percentage. Furthermore, the authors showed that one of the SNPs (rs9527) was associated with skin lesion risk through case-control comparison (36) . Although the role of AS3MT in arsenic metabolism has been previously described (37) , two novel SNPs (rs9527 and rs11191527) not strongly correlated with any previously reported SNPs were identifi ed.
Genetic susceptibility to arsenic-related health outcomes has been evaluated by several candidate gene studies in the last decade (38) . Despite this, the limited scope of work that has been done to evaluate genetic susceptibility to arsenic toxicity clearly warrants further investigation. It is hoped that additional GWAS and replication studies will overcome obstacles in the existing literature including inconsistencies in case defi nitions, differences in arsenic exposure distributions across populations as well as other covariates, and underpowered studies to be able to synthesize genetic risk factors of arsenic toxicity from future research.
Biological responses of prenatal arsenic exposure
The health effects of prenatal arsenic exposure have been recently reviewed by Vahter (39) . There is increasing epidemiologic evidence of the association of infant growth and mortality with prenatal arsenic exposure; however, the question still remains regarding later-life health effects of prenatal and early life arsenic exposure (40) . Few epidemiologic studies have evaluated health outcomes in relation to early life arsenic exposure (41 -43) , although there is some evidence from research in Chile of increased mortality rates associated with prenatal and early life arsenic exposure (41) . Molecular biomarkers of early biological effects have been increasingly studied in arsenic epidemiology to elucidate information on toxicity mechanisms and biological pathways. The examination of cellular and molecular responses associated with prenatal arsenic exposure is a fi rst step in a life course approach to evaluate early childhood exposure with potential later-life health outcomes.
In a recent study of mothers and newborns in Thailand, gene expression signals from babies born to arsenic-exposed and arsenic-unexposed mothers were evaluated (44) . The authors identifi ed 11 gene transcripts predictive of prenatal arsenic exposure, including up-regulation of molecular networks related to stress, infl ammation, metal exposure, and apoptosis in the newborns. Additionally, NF-κ B and IL-1 β was one of the networks observed to underlie the set of differentially expressed genes between infants from arsenicexposed and arsenic-unexposed mothers, a pathway related to infl ammation and apoptosis. Interestingly, the NF-κ B and IL-1 β pathway was previously shown to be differentially expressed in a comparison of Bangladeshi adults with and without arsenical skin lesions (45) . Another recent study of newborns in Thailand showed that arsenic-exposed newborns had signifi cantly higher levels of arsenic in cord blood, fi ngernails, toenails, and hair and a slight increase in promoter methylation of p53 in cord blood lymphocytes compared with the newborns of arsenic-unexposed mothers (46) . Additional biological effects should be characterized in infants, children, and adolescents to evaluate the effect of prenatal and early life arsenic exposure, including further and more comprehensive investigation of epigenetic effects, which are potentially modifi able and can be the target of future interventions.
Public health implications
The worldwide prevalence of arsenic in drinking water illustrates the fact that arsenic exposure is a major public health concern deserving attention. There are two major public health considerations with respect to arsenic exposure, which we describe in the context of primary and secondary prevention.
Primary prevention
Arsenic mitigation is a critical public health need in exposed populations, with progress being made toward eliminating arsenic exposure through drinking water sources in the human population. Mitigation efforts have largely taken two forms in arsenic-exposed populations: well switching and arsenicremoval technologies.
One of the approaches to mitigation taken in the Araihazar region of Bangladesh has focused on taking advantage of the high degree of spatial variability of arsenic in groundwater, the consequence of which is that a majority of residents in the area live within walking distance of a tube well that is low in arsenic (47) . Surveys as well as time-series measurements of urinary arsenic have shown that reporting the results of tube well testing, along with education on the health risks of arsenic in drinking water, has led a substantial portion of households to switch to a nearby low arsenic well, markedly reducing exposure to arsenic throughout the geographic study area (48, 49) . In areas with little opportunity for sharing existing low arsenic wells, the installation of community wells by a local organization has been facilitated, tapping deeper low arsenic aquifers (50) . However, despite the discovery of arsenic-enriched groundwater in South and Southeast Asia, new wells continue to be installed blindly without regard to possible arsenic contamination. Observations from Bangladesh indicate that a large proportion of new tube wells that are installed are not immediately tested for their arsenic concentration; thus, there is the continuous need for testing of new tube wells, which can be reliably achieved through fi eld kits (51) .
Arsenic-removal technologies are another mitigation strategy used in arsenic-exposed regions of South and Southeast Asia. A comprehensive review of arsenic-removal technologies has recently been conducted by Jain and Singh (52) . There are complex interactions and logistical considerations that should be considered for the large-scale implementation of arsenic-removal technologies in populations including the selection of a technology appropriate for the concentration of arsenic found in the groundwater, the economic condition and feasibility of the technology for the population, the population distribution in the geographic area, the technology and labor skill available for the technology operation and maintenance in the population, and environmental impacts (53) . Besides the complication of properly maintaining arsenic-removal technologies at the household or community level, there is also concern about the likelihood of microbial contamination of fi ltration systems in regions where sanitation is still very poor.
Secondary prevention
The second major public health consideration is preventing or reducing harm after chronic arsenic exposure has occurred. Although there is substantial evidence of dose-response associations between arsenic in drinking water and various health outcomes, studies have shown that remediation of arsenic exposure alone does not reduce arsenic-related health risks in the population (54 -56) . Recent publications using prospective data from the Health Effects of Arsenic Longitudinal Study cohort have shown (using repeated measures of urinary total arsenic exposure over time) that, once chronically exposed, a reduction of exposure for a short amount of time did not reduce one ' s risk of mortality (54) or skin lesion incidence (57) . Furthermore, studies from Taiwan and Chile indicate that an elevated cancer risk among arsenic-exposed populations persists for at least several decades after cessation of exposure (9, 58, 59) . Therefore, evidence from these previous studies suggests that it may be important to consider other health prevention and promotion strategies in conjunction with remediation for arsenic-exposed populations. The evaluation of genetic determinants of arsenic-related health outcomes as well as epigenetic modifi cations associated with exposure could contribute to a greater understanding of the genetic and molecular pathways that underlie arsenic toxicity and may inform future interventions and secondary prevention strategies of arsenic-exposed populations. In addition to elucidating biological mechanisms of action, investigating genetic susceptibility may help identify individuals with higher risk to arsenic-related toxicity, aiding in secondary prevention and intervention of arsenic-exposed populations.
Conclusions
Estimation of the future public health burden of arsenic exposure through drinking water has been primarily extrapolated from data from other populations (60 -62) . Although the exact magnitude of these estimates may be uncertain, it is clear that millions of individuals in South and Southeast Asia are at an increased risk of arsenic-related diseases and mortality. Future public health research should emphasize arsenic mitigation in the most severely affected regions. Additionally, future molecular and genetic epidemiologic fi ndings may have potential translational implications for prevention and treatment of arsenic-associated toxicities worldwide.
